logo

For the Inventor, By the Inventor

Corvallis, OR, United States of America

Avi Biopharma, Inc.


USPTO Granted Patents = 50



Trademarks = 2

Forward Citations = 2,016

Loading Chart...
Loading Chart...

40 inventors (with patents filed for the assignee):

goldMedal Patrick L Iversen (43 out of 95 patents)

silverMedal Dwight D Weller (22 out of 61 patents)

bronzeMedal David A Stein (14 out of 24 patents)

4.  Sina Bavari (5 out of 28 patents)

5.  Bruce L Geller (4 out of 16 patents)

6.  Hong M Moulton (4 out of 9 patents)

7.  Robert Hudziak (3 out of 6 patents)

8.  Jed N Hassinger (3 out of 8 patents)

9.  Dan V Mourich (3 out of 11 patents)

10.  James E Summerton (3 out of 20 patents)

11.  Michelle H Nelson (2 out of 4 patents)

12.  Andrew D Kroeker (2 out of 4 patents)

13.  Lucas D Tilley (2 out of 6 patents)

14.  Jesse D Deere (2 out of 3 patents)

15.  Stephen H Bartelmez (2 out of 3 patents)


Core Competencies:
Antisense Oligomers
Molecular Transport
Immunomodulatory Agents
Oligonucleotide Analogs
Morpholino Oligomers
Cancer Treatment
Antiviral Compounds
Antibacterial Methods
Gene Therapy
Splice-Switching Oligonucleotides
Microparticle Drug Delivery
RNA Detection

50 patents:

1. 9572899 - Compositions for enhancing transport of molecules into cells (2017-02-21),
2. 8524684 - Antisense antiviral compounds and methods for treating a filovirus infection (2013-09-03),
3. 8436163 - Splice-region antisense composition and method (2013-05-07),
4. 8415313 - Antisense oligomers and methods for inducing immune tolerance and immunosuppression (2013-04-09),
5. 8357664 - Antisense antiviral compound and method for treating influenza viral infection (2013-01-22),
6. 8329668 - Antisense antiviral compound and method for treating picornavirus infection (2012-12-11),
7. 8314072 - Antisense antibacterial method and compound (2012-11-20),
8. 8299206 - Method of synthesis of morpholino oligomers (2012-10-30),
9. 8198429 - Antisense antiviral compounds and methods for treating a filovirus infection (2012-06-12),
10. 8168604 - Antisense antiviral compounds and methods for treating a filovirus infection (2012-05-01),
11. 8129352 - Antisense antiviral compound and method for treating ssRNA viral infection (2012-03-06),
12. 8084433 - Antisense antiviral compound and method for treating ssRNA viral infection (2011-12-27),
13. 8076476 - Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits (2011-12-13),
14. 8067571 - Antibacterial antisense oligonucleotide and method (2011-11-29),
15. 8067569 - Splice-region antisense composition and method (2011-11-29),
AVI BIOPHARMA, INC. is a biopharmaceutical company focused on the development of RNA-based therapeutics. They employ innovative technologies to create drugs that target and inhibit disease-causing genes. AVI BIOPHARMA aims to provide effective treatment options for patients suffering from various diseases, including genetic disorders and viral infections.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

50 Patents

#6 in Corvallis, OR

#79 in Oregon

#6,771 in US

#13,590 in the World

...
Corvallis, OR, United States of America

Avi Biopharma, Inc.

Forward Citations = 2,016

40 inventors:

goldMedal Patrick L Iversen (43 out of 95 patents)

silverMedal Dwight D Weller (22 out of 61 patents)

bronzeMedal David A Stein (14 out of 24 patents)

4.  Sina Bavari (5 out of 28 patents)

5.  Bruce L Geller (4 out of 16 patents)

Please report any incorrect information to support@idiyas.com
Loading…